Literature DB >> 15300187

Gene expression profiles post Roux-en-Y gastric bypass.

Yuan Xu1, Eduardo J b Ramos, Frank Middleton, Irina Romanova, Robert Quinn, Chung Chen, Undurti Das, Akio Inui, Michael M Meguid.   

Abstract

BACKGROUND: The hypothalamus is involved in regulation of food intake (FI) and fat deposition. Molecular mechanisms of weight loss after Roux-en-Y gastric bypass (RYGB) were studied by correlating changes in gene expression profiles in hypothalamic arcuate nucleus (ARC) and subcutaneous abdominal fat (SAF).
METHOD: Diet-induced obese rats were divided into RYGB, sham-operated (SO-Obese), and sham-operated pair-fed (PF) groups. A non-obese group on a regular chow diet served as control. Body weight (BW) and FI were measured. Rats were killed 10 days after the operation. Plasma was analyzed for biochemical indices, ARC and SAF were analyzed for gene expression profiles. Body SAF was also weighed. Data were analyzed by ANOVA and factor analysis.
RESULTS: BW and FI decreased in RYGB versus SO-Obese, as reflected by decreased SAF (53%). Genes similarly expressed in ARC and SAF after RYGB were limited to several genes that predominantly related to metabolic pathways of carbohydrate, fat, neuropeptide, and cytokines. These expression profiles were similar to those seen in chow control and to those seen in a comparison of PF and SO-Obese.
CONCLUSIONS: RYGB-induced weight loss is associated with changes in gene profile expressions that could influence metabolic changes, contributing to weight loss. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300187     DOI: 10.1016/j.surg.2004.04.027

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

Review 1.  Animal models in bariatric surgery--a review of the surgical techniques and postsurgical physiology.

Authors:  Raghavendra S Rao; Venkatesh Rao; Subhash Kini
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

2.  Mechanism of gastric bypass-induced body weight loss: one-year follow-up after micro-gastric bypass in rats.

Authors:  Björn Stenström; Marianne W Furnes; Karin Tømmerås; Unni Syversen; Chun-Mei Zhao; Duan Chen
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy.

Authors:  Yong Wang; Jingang Liu
Journal:  Obes Surg       Date:  2008-10-08       Impact factor: 4.129

Review 4.  Changes in neurohormonal gut peptides following bariatric surgery.

Authors:  C N Ochner; C Gibson; M Shanik; V Goel; A Geliebter
Journal:  Int J Obes (Lond)       Date:  2010-07-13       Impact factor: 5.095

Review 5.  Pathophysiology of obesity: why surgery remains the most effective treatment.

Authors:  Talat Waseem; Kris M Mogensen; David B Lautz; Malcolm K Robinson
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

6.  Sustained weight loss after Roux-en-Y gastric bypass is characterized by down regulation of endocannabinoids and mitochondrial function.

Authors:  Ana Guijarro; Douglas Osei-Hyiaman; Judith Harvey-White; George Kunos; Susumu Suzuki; Sergiy Nadtochiy; Paul S Brookes; Michael M Meguid
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

7.  Bariatric Surgery to Correct Morbid Obesity Also Ameliorates Atherosclerosis in Patients with Type 2 Diabetes Mellitus.

Authors:  Yong Wang; Cuihua Zhang
Journal:  Am J Biomed Sci       Date:  2009-01-01

8.  Is the colon mucosa affected by ten days of gastric restriction in an animal model?

Authors:  Flávia Emi Akamatsu; Luiz Gustavo Fontes; Ana Maria Itezerote; Samir Saleh; Walcy Paganelli Rosolia Teodoro; Everson Artifon; Flávio Hojaij; Mauro Andrade; José Aires Pereira; Carlos Augusto Real Martinez; Alfredo Luiz Jacomo
Journal:  Acta Cir Bras       Date:  2019-08-19       Impact factor: 1.388

9.  Gene expression profile in obesity and type 2 diabetes mellitus.

Authors:  Undurti N Das; Allam A Rao
Journal:  Lipids Health Dis       Date:  2007-12-14       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.